After proposing in February a 1.9 percent cut in reimbursement to insurers in the Medicare Advantage program, Medicare made a surprise announcement and said there would, instead, be a 0.4 percent increase. This is the second year Medicare...
Researchers have found a major piece of genetic evidence that confirms the role of a group of virus-fighting genes in cancer development.
In a new study, researchers from North Carolina State University, UNC-Chapel Hill and other institutions have taken the first steps toward creating a road map that may help scientists narrow down the genetic cause of numerous diseases.
The FDA has lifted a clinical hold placed on a study at Memorial Sloan-Kettering of Juno Therapeutics' cutting-edge approach to treating cancer using genetically tailored T cells. "I confirm that the FDA has rapidly lifted the...
Millions of Americans with Type 2 diabetes have a new treatment option with the U.S. Food and Drug Administration's approval of a once-weekly injectable drug, Tanzeum. The FDA described Tanzeum as a "glucagon-like peptide-1 receptor agonist — a hormone that helps...
The federal healthcare overhaul is providing coverage for millions of Americans, but it has only chipped away at one of its core goals: to sharply reduce the number of people without insurance. President Barack Obama announced...
It's back. For years, because of structural changes in the healthcare delivery system and the deep economic downturn, the healthcare "cost curve" — as economists and policy makers call it — had bent. Health spending was growing no faster than spending on other...
Subscribe to Genomics Biotechnology & Emerging Medical Technologies Institute e-News
|State / Province:|
|Are you a member of NAMCP?||Yes No|